Technology Analysis Cell-based Flow Cytometry segment accounted for the most significant market growth in 2022. The cell-based Flow Cytometry segment is driven by advancements in technology, such as ...

Flow cytometry (FC) is a powerful tool for multi-parametric cell characterization. In this article, we explore the advances improving the accuracy and efficiency of FC and opening up new research and ...

The Life Sciences Research Facility and the Nano Research Facility are home to the university’s Imaging and Flow Cytometry Core. This open access resource, developed and managed by DCU Core ...

Flow cytometry is an invaluable method for biomedical research. Since its development over 50 years ago, technology for flow cytometry has progressed rapidly, allowing for the detection of more and ...

The market is expected to grow at a CAGR of around 7% from 2021 to 2028. The use of flow cytometry in cancer research and diagnostics is a major contributor to this growth.

The modern flow cytometer is able to make measurements of cells in solution as they pass by the instrument’s laser. Today’s instruments offer an increased number of detectable fluorescent parameters ...

Flow Cytometry IndustryThe global flow cytometry industry size is gearing up for unprecedented growth, marking a transformative journey from a valuation of US$ 5.6 Billion in 2022 to an anticipated ...

The flow cytometry market research report is one of a series of new reports that provides flow cytometry market statistics, including flow cytometry industry global market size, regional shares ...

DiaSorin's subsidiary Luminex Corporation will sell its Flow Cytometry & Imaging (FCI) business unit to Cytek Biosciences Inc (NASDAQ: CTKB). Deal terms were not disclosed. The FCI business unit ...

Report Scope: This report aims to provide a comprehensive study of the global market for flow cytometry, both in terms of quantitative and qualitative data, to help readers develop business/growth ...